Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
China
Ethics Committee of Shanghai Renji Hospital, Shanghai, Shanghai Municipality Age range
18 Years – 90 Years
Last updated December 2025